These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30206484)

  • 1. Metabolic Modulation of Cardiac Metabolism in Heart Failure.
    Rosano GM; Vitale C
    Card Fail Rev; 2018 Aug; 4(2):99-103. PubMed ID: 30206484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    Lopatin YM; Rosano GM; Fragasso G; Lopaschuk GD; Seferovic PM; Gowdak LH; Vinereanu D; Hamid MA; Jourdain P; Ponikowski P
    Int J Cardiol; 2016 Jan; 203():909-15. PubMed ID: 26618252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.
    Byrne NJ; Levasseur J; Sung MM; Masson G; Boisvenue J; Young ME; Dyck JR
    Cardiovasc Res; 2016 May; 110(2):249-57. PubMed ID: 26968698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure.
    Kärkkäinen O; Tuomainen T; Mutikainen M; Lehtonen M; Ruas JL; Hanhineva K; Tavi P
    Cardiovasc Res; 2019 Jan; 115(1):107-118. PubMed ID: 29931052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetazidine in cardiovascular medicine.
    Marzilli M; Vinereanu D; Lopaschuk G; Chen Y; Dalal JJ; Danchin N; Etriby E; Ferrari R; Gowdak LH; Lopatin Y; Milicic D; Parkhomenko A; Pinto F; Ponikowski P; Seferovic P; Rosano GMC
    Int J Cardiol; 2019 Oct; 293():39-44. PubMed ID: 31178223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic therapy for the diabetic patients with ischaemic heart disease.
    Rosano GM; Vitale C; Volterrani M; Fini M
    Coron Artery Dis; 2005 Nov; 16 Suppl 1():S17-21. PubMed ID: 16340399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts.
    Birkenfeld AL; Jordan J; Dworak M; Merkel T; Burnstock G
    Pharmacol Ther; 2019 Feb; 194():132-144. PubMed ID: 30149104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic therapy of heart failure.
    Fragasso G; Salerno A; Spoladore R; Bassanelli G; Arioli F; Margonato A
    Curr Pharm Des; 2008; 14(25):2582-91. PubMed ID: 18991675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects.
    Gong FF; Campbell DJ; Prior DL
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1504-1519. PubMed ID: 29216977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
    Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
    J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trimetazidine in nonischemic heart failure: a randomized study.
    Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S
    J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.
    Kawaguchi M; Hay I; Fetics B; Kass DA
    Circulation; 2003 Feb; 107(5):714-20. PubMed ID: 12578874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Interventions Effective in Improving Exercise Capacity in Heart Failure.
    Vitale C; Ilaria S; Rosano GM
    Card Fail Rev; 2018 May; 4(1):25-27. PubMed ID: 29892472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure.
    Fragasso G
    Card Fail Rev; 2016 May; 2(1):8-13. PubMed ID: 28785448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of carvedilol on ryanodine receptor in heart failure].
    Li R; Yi QJ; Qian YR; Liu XY
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
    Zile MR; Kjellstrom B; Bennett T; Cho Y; Baicu CF; Aaron MF; Abraham WT; Bourge RC; Kueffer FJ
    Circ Heart Fail; 2013 May; 6(3):508-16. PubMed ID: 23515277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular fluid dynamics in heart failure: echocardiographic measurement and utilities of vortex formation time.
    Poh KK; Lee LC; Shen L; Chong E; Tan YL; Chai P; Yeo TC; Wood MJ
    Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):385-93. PubMed ID: 22180464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
    Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.